East Annual Conference

Location: Boston, MA
Date: September 11-14, 2014

Meeting Overview

Venue:
Boston Convention & Exhibition Center
Primary Audience:
Primary Care
Credits:
Please refer to the Accreditation Tab
Untitled Document

For those who look to you—you can look to us.

Primary care is where good health begins. It is based on your relationship with your patients as you provide and coordinate the care they need, from preventive health to specialty care to inpatient services. The demands and challenges you face every day within your practice are constantly changing, so we’re changing with them.

We’ve taken the feedback of clinicians in your region and across the country to launch an all-new Annual Conference.

Registration opening soon!

Pri-Med Show


Earn up to 26 AMA PRA Category 1 Credits™ or 26 AANP contact hours of continuing education.



Quality CME

Pri‑Med has expanded its partnership with the American College of Physicians (ACP), and in collaboration with the ACP we are unveiling an entirely new cutting-edge CME curriculum.

The CME sessions will include the latest treatments and therapies, such as:

  • Live Demonstration Orthopedic Exam:
    See It, Do It
  • Obstructive Sleep Apnea: Interventions That Will Help Your Patients Sleep Better
  • In Search of Joy in Practice

Curriculum developed in collaboration with the ACP

Session Schedule

 

Value for Your Time

In addition to over 30 new educational sessions, there are many new components of the conference that were created with you in mind.

  • Renowned keynote speakers including Dr. Michael Dansinger, a weight loss and nutrition consultant for NBC’s The Biggest Loser
  • SAFE Opioid Prescribing certification sessions featuring a faculty meet and greet and book signing
  • A chance to participate in hands-on ultrasound workshops developed with the University of South Carolina School of Medicine Ultrasound Institute

University of South Carolina School of Medicine

Keynote Speakers



CME Activities

Primary Care Updates* | September 11, 2014
Earn up to 7 AMA PRA Category 1 Credits™ or 7 AANP contact hours of continuing education at these pre-conference sessions.

Annual Conference | September 12–14, 2014
Earn up to 19 AMA PRA Category 1 Credits™ or 19 AANP contact hours of continuing education during the core curriculum.


Educational Symposia
Accredited CME sessions to expand your learning during breaks from the core curriculum.

Learn More

 

Industry-Sponsored Opportunities

Exhibit Hall
Have face-to-face conversations with industry professionals, gain helpful takeaways, and experience engaging floor activities such as live demonstrations, outside your office hours.

Presentation Theaters
Live discussions led by prominent medical thought leaders. Get an in-depth look at the latest tools and treatment options.

Presentation Theaters are not offered for CME credit nor is the content planned or reviewed by pmiCME, ACP, or USC.

Learn More

How to Register

Registration is opening soon!

Register online

Returning Attendees: You will need to log in to your Pri‑Med Online account. Your username is your email address.

New Pri-Med members: Create a new account in just minutes for access to live event registration and our extensive library of online CME activities.

 


Register for Pri-Med East by:

May 30 for: $30
July 11 for: $40
August 15 for: $55
September 7 for: $75
On-site at Pri-Med East for $100

Prices represent online registration; registration by
phone is an additional $10.

Pri-Med Mobile App Coming Soon

*Primary Care Updates tracks are sponsored by pmiCME and are produced independently of and are not affiliated with the ACP or USC. This is a limited-capacity ticketed event available during registration.

Sessions & Syllabus

CLOSE  X  
Registration & Breakfast
CLOSE  X  
Registration & Breakfast
CLOSE  X  
Registration & Breakfast
CLOSE  X  
Opening Remarks
CLOSE  X  
Opening Remarks
CLOSE  X  
Opening Remarks
CLOSE  X  
Session Information to Come
CLOSE  X  
Improving Outcomes for Acute Coronary Syndrome Patients: Best Practices for Primary Care Clinicians
Learning Objectives:
  1. Summarize fundamental similarities and differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics of oral antiplatelet drugs.
  2. Explain efficacy and safety data with oral antiplatelet therapies from ACS outcomes trials.
  3. Recognize guideline-based therapies to reduce risk and goals to achieve in the management of patients who have experienced an acute coronary syndrome.
Faculty:
  1. Jessica Mega, MD , MPH
  2. Benjamin Scirica, MPH, MD, Assistant Professor, Harvard Medical SchoolBoston, MA, TIMI Study Group, Cardiovascular Division, Brigham and Women's HospitalBoston, MA (Bio)
CLOSE  X  
Session Information to Come
CLOSE  X  
AM Break
CLOSE  X  
AM Break
CLOSE  X  
AM Break
CLOSE  X  
Session Information to Come
CLOSE  X  
Addressing Renal-Mediated Glucose Homeostasis: Diabetes and the Kidney
Learning Objectives:
  1. Recognize the role of the renal system in glucose uptake, reabsorption, and the maintenance of glucose homeostasis and use the achieved knowledge to identify patients who would benefit from renally-targeted therapies.
  2. Explain the mechanism of action of sodium glucose linked transporter inhibitors and their role in modulating glucose homeostasis.
  3. Review professional guidelines from the ADA and AACE for target goals of therapy and treatment recommendations for specific patient-types.
  4. Identify the safety and efficacy profiles of current and emerging therapies that target renally-mediated glucose uptake and reabsorption.
  5. Implement management strategies that incorporate current and emerging therapies into treatment paradigms for patients who would benefit from a targeted approach to glycemic control.
Faculty:
  1. William Sullivan, MD, Assistant Clinical Professor of Medicine, Harvard Medical SchoolBoston, MA, Senior Physician, Joslin Diabetes CenterBoston, MA
CLOSE  X  
Session Information to Come
CLOSE  X  
Improving Outcomes in Type 2 Diabetes: The Role of GLP-1 Receptor Agonists in Multimodal Treatment Regimens
Learning Objectives:
  1. Discuss the pathologic mechanisms of T2DM that support the need for prompt diagnosis and aggressive treatment.
  2. Identify patient-centered treatment goals for patients with T2DM that encompass good overall glycemic control and improvements in other clinical parameters.
  3. Evaluate the clinical profiles of GLP-1 receptor agonists for the treatment of T2DM.
  4. Individualize therapeutic regimens for T2DM to maximize efficacy and minimize hypoglycemia, weight gain, and other potential treatment-related risks.
  5. Communicate with patients with T2DM about lifestyle modifications, antihyperglycemic options, and the need for treatment adherence.
CLOSE  X  
Against All Odds: Improving Insulin Use in T2DM through Individualized Clinical Decision Making
Learning Objectives:
  1. Summarize the clinical evidence supporting the use of basal insulin therapy, with and without GLP-1 receptor agonists, in the management of type 2 diabetes.
  2. Incorporate strategies to overcome barriers to insulin use in the treatment of type 2 diabetes.
Faculty:
  1. Frank Lavernia, MD (Bio)
  2. Paul Jellinger, MD
  3. Richard Pratley, MD (Bio)
CLOSE  X  
Session Information to Come
CLOSE  X  
Lunch Break
CLOSE  X  
Lunch Break
CLOSE  X  
Lunch Break
CLOSE  X  
Managing Shift Work Disorder in Primary Care: Overcoming Barriers to Improve Patient Outcomes
Learning Objectives:
  1. Describe the neurophysiologic mechanisms of circadian rhythms and adverse multisystem consequences of misalignment for patient health and function.
  2. Evaluate sleep patterns and symptoms of shift work disorder using clinical tools and strategies, such as sleep logs and the Epworth Sleepiness Scale.
  3. Diagnose shift work disorder based on identified symptoms, patient history and work schedule, and a comprehensive sleep history.
  4. Tailor therapeutic regimens for shift work disorder that include appropriate combinations of nonpharmacologic and pharmacologic modalities.
  5. Educate patients on the potential consequences of poorly managed shift work disorder and the fundamentals of sleep hygiene.
Faculty:
  1. Karl Doghramji, MD, Professor of Psychiatry, Neurology, and Medicine, Medical Director, Jefferson Sleep Disorders Center, Program Director, Fellowship in Sleep Medicine, Thomas Jefferson UniversityPhiladelphia, PA (Bio)
  2. Paul Doghramji, FAAFP , MD, Family Physician, Collegeville Family PracticeCollegeville, PA, Medical Director of Health Services, Ursinus CollegeCollegeville, PA (Bio)
  3. Charles Czeisler, MD, PhD, Baldino Professor of Sleep Medicine, Harvard Medical SchoolBoston, MA, Senior Physician, Division of Sleep Medicine, Department of Medicine, Brigham and Women's HospitalBoston, MA
CLOSE  X  
Session Information to Come
CLOSE  X  
The Evaluation and Treatment of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms in the Primary Care Setting
Learning Objectives:
  1. Describe the pathophysiology and common comorbidities of BPH/LUTS.
  2. Implement comprehensive assessment of patients with BPH/LUTS.
  3. Select treatment options available to effectively treat BPH/LUTS.
Faculty:
  1. Martin Miner, MD, Chief of Primary Care and Community Medicine, The Miriam HospitalProvidence, RI, Clinical Clinical Co-Director, Men's Health Center, Associate Professor of Family Medicine and Urology, Warren Alpert Medical School, Brown UniversityProvidence, RI (Bio)
  2. Matt T Rosenberg, MD, Director and Founder, Mid-Michigan Health CentersJackson, MI
CLOSE  X  
PM Break
CLOSE  X  
Session Information to Come
CLOSE  X  
PM Break
CLOSE  X  
PM Break
CLOSE  X  
Insulin Therapy in Patients with Type 2 Diabetes: Current and Emerging Basal Insulins
Learning Objectives:
  1. Outline the benefits of early insulin therapy in patients with type 2 diabetes.
  2. Discuss when insulin may be initiated for the treatment of patients with type 2 diabetes.
  3. Describe the advantages and disadvantages of various insulin regimens and apply them in clinical practice for the selection and titration of insulin in patients with type 2 diabetes.
  4. Identify the barriers to insulin-mediated glucose control and apply strategies to overcome them.
  5. Describe how improved pharmacokinetic and pharmacodynamic profiles of emerging insulins may reduce hypopglycemia and optimize insulin administration.
CLOSE  X  
Current Perspectives and Emerging Approaches in Lipid Management
Learning Objectives:
  1. Evaluate primary and secondary prevention evidence with statins.
  2. Explain the importance of lowering LDL-C for reducing cardiovascular risk, interpret statin safety data, and assess benefit/risk with statins.
  3. Explain the association of hypertriglyceridemia with increased risks and identify currently available therapies for reducing elevated triglycerides.
  4. Discuss similarities and differences between currently available and emerging omega-3 fatty acid agents, and indicate patient populations for potential incorporation of omega-3 fatty acids in clinical practice.
Faculty:
  1. Eliot Brinton, MD, FAHA , FNLA, Associate Professor of Medicine, University of Utah School of MedicineSalt Lake City, UT (Bio)
  2. JoAnne Foody, MD, FACC, FAHA, Associate Professor of Medicine, Harvard Medical SchoolBoston, MA (Bio)
Primary Care Updates Track 1
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 1: Bristol-Myers Squibb and AstraZeneca LP, AstraZeneca and Teva CNS.
Primary Care Updates Track 2
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 2: AstraZeneca and Sanofi US Diabetes.
Primary Care Updates Track 3
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 3: Novo Nordisk Inc., Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com and AstraZeneca.
6:45AM
 
7:15AM
 
7:45AM
 
8:15AM
 
8:45AM
 
9:15AM
 
9:45AM
 
10:15AM
 
10:45AM
 
11:15AM
 
11:45AM
 
12:15PM
 
12:45PM
 
1:15PM
 
1:45PM
 
2:15PM
 
2:45PM
 
3:15PM
 
3:45PM
 
6:45 AM-7:35 AM - Registration & Breakfast
6:45 AM-7:35 AM - Registration & Breakfast
6:45 AM-7:35 AM - Registration & Breakfast
   
   
7:35 AM-7:45 AM - Opening Remarks
7:35 AM-7:45 AM - Opening Remarks
7:35 AM-7:45 AM - Opening Remarks
7:45 AM-9:00 AM
Session Information to Come
7:45 AM-9:15 AM
Improving Outcomes for Acute Coronary Syndrome Patients: Best Practices for Primary Care Clinicians
7:45 AM-9:00 AM
Session Information to Come
   
   
   
   
9:00 AM-9:15 AM - AM Break
 
9:00 AM-9:15 AM - AM Break
9:15 AM-10:30 AM
Addressing Renal-Mediated Glucose Homeostasis: Diabetes and the Kidney
9:15 AM-9:30 AM - AM Break
9:15 AM-10:45 AM
Session Information to Come
 
9:30 AM-10:45 AM
Session Information to Come
 
   
   
   
10:30 AM-11:45 AM
Improving Outcomes in Type 2 Diabetes: The Role of GLP-1 Receptor Agonists in Multimodal Treatment Regimens
  
 
10:45 AM-12:00 PM
Session Information to Come
10:45 AM-12:15 PM
Against All Odds: Improving Insulin Use in T2DM through Individualized Clinical Decision Making
   
   
   
11:45 AM-12:30 PM - Lunch Break
  
 
12:00 PM-12:45 PM - Lunch Break
 
  
12:15 PM-1:00 PM - Lunch Break
12:30 PM-1:45 PM
Managing Shift Work Disorder in Primary Care: Overcoming Barriers to Improve Patient Outcomes
  
 
12:45 PM-2:15 PM
Session Information to Come
 
  
1:00 PM-2:15 PM
The Evaluation and Treatment of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms in the Primary Care Setting
   
   
1:45 PM-2:00 PM - PM Break
  
2:00 PM-3:30 PM
Session Information to Come
  
 
2:15 PM-2:30 PM - PM Break
2:15 PM-2:30 PM - PM Break
 
2:30 PM-4:00 PM
Insulin Therapy in Patients with Type 2 Diabetes: Current and Emerging Basal Insulins
2:30 PM-3:45 PM
Current Perspectives and Emerging Approaches in Lipid Management
   
   
   
   
   
CLOSE  X  
Registration and Refreshments
CLOSE  X  
Welcome and Opening Remarks
CLOSE  X  
Obesity in America from the Dietary Counselor and Lifestyle Coach from "The Biggest Loser"
Getting your patients to lose weight is never easy. Learn in this keynote address from the weight loss and nutrition consultant to NBC's "The Biggest Loser" about effective lifestyle and behavioral approaches to achieve weight loss goals in your overweight and obese patients.
Learning Objectives:
  1. Employ proven, evidence-based lifestyle and behavioral modalities to help your obese patients lose weight and achieve health benefits.
Faculty:
  1. Michael Dansinger, MD (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Targeting Better Cardiac Outcomes for High-Risk Patients
This session will provide important update information on low HDL-C levels and elevated triglycerides as therapeutic targets to reduce cardiovascular disease risk.
Learning Objectives:
  1. Evaluate recent clinical trials with respect to management of low HDL.
  2. Examine the data on triglycerides and CVD risk to determine how aggressively to treat patients with elevated TGs.
  3. Employ strategies for reducing CVD risk in patients with type 2 diabetes and hypertension.
CLOSE  X  
Ultrasound in Primary Care
CLOSE  X  
Understanding Dyslipidemia Testing and Screening: Importance of Lipoprotein Particle Analysis
This session will provide new insight into the pathogenesis of dyslipidemia in the type 2 diabetic patient with chronic kidney disease and the rationale for advanced lipid testing (i.e., lipoprotein particle analysis) in those patients at high CV risk.
Learning Objectives:
  1. Describe the pathogenesis of dyslipidemias in patients with diabetes and chronic kidney disease.
  2. Understand the rationale for performing lipoprotein particle analysis in patients with high CV risk comorbidities.
CLOSE  X  
Introduction to Ultrasound and Case Presentations
CLOSE  X  
Networking Break and Addtional Opportunities
CLOSE  X  
Engaging e-Patients: How e-Messaging, Personal Health Records, and Patient Activation Can Transform Your Practice
Participatory medicine is being driven by e-health technology and represents a significant paradigm shift. Learn how e-messaging, patient health records/patient portals and online resources can improve and are improving patient care through improved communication between you and your patients.
Learning Objectives:
  1. Take advantage of online resources to expand your medical knowledge and augment your clinical expertise.
  2. Provide practical advice to patients about smart and appropriate use of web-based health information and social media.
CLOSE  X  
Evaluation is Essential for Safe and Effective Pain Management Using ER/LA Opioids
Learning Objectives:
  1. Identify risk factors for opioid-related aberrant behavior
  2. Differentiate between tolerance, physical dependence and addiction
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Ultrasound Workshops | Hands-on workshops developed with the University of South Carolina Ultrasound Institute offered at an additional cost
Ultrasound Workshops will include six rotating modules on: Ultrasound Hand-held and Pocket Devices, Heart Overview, Ultrasound-Guided Procedures in the Musculoskeletal, Aorta and Inferior Vena Cava, Liver and Gallbladder, Ultrasound principles and instrumentation
CLOSE  X  
Best Practices for How to Start Therapy with ER/LA Opioids, How to Stop, and What to Do in Between
Learning Objectives:
  1. Convert patients from immediate-release to ER/LA opioids as well as from one ER/LA opioid to another
  2. Identify predisposing risk factors for significant respiratory depression
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Test Your Skills in Difficult Cases: Atrial Fibrillation
Participatory medicine is being driven by e-health technoloogy and represents a significant paradigm shift. Learn how e-messaging, patient health records/patient portals and online resources can and are improving patient care through improved communication between you and your patients.
Learning Objectives:
  1. Take advantage of online resources to expand your medical knowledge and augment your clinical expertise.
  2. Provide practical advice to patients about smart and appropriate use of web-based health information and social media.
CLOSE  X  
Evidence-Based Tools for Screening for Patients at Risk and Monitoring for Adherence to Prescribed ER/LA Opioids
Learning Objectives:
  1. Evaluate and manage adverse effects of ER/LA-opioids
  2. Differentiate strategies for monitoring patient adherence
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Networking Break
CLOSE  X  
An Algorithmic Approach to Diabetes Management: Insulin-Based Therapy
Sequential insulin strategies recommended by the ADA/EASD will be reviewed, and evidence-based insulin regimens will be provided that can be used to initiate treatment that gets type 2 diabetic patients to their A1c goals.
Learning Objectives:
  1. Describe the sequential insulin strategies approach recommended by recent guidelines.
  2. Apply evidence-based insulin strategies to help patients with type 2 diabetes achieve their HbA1C goals.
CLOSE  X  
Talk to Me: Proven Methods to Counsel Your Patients on ER/LA Opioids and Achieve Positive Outcomes
Learning Objectives:
  1. Implement counseling strategies to ensure patients know to take ER/LA opioids exactly as prescribed
  2. Use counseling strategies to explain signs of ER/LA opioid overdose to patients and caregivers
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Everything You Always Wanted to Know About ER/LA-Opioids as a Drug Class
Learning Objectives:
  1. Assess the differences in opioid metabolism and how these impact appropriate ER/LA prescribing
  2. Identify how opioid-drug interactions influence ER/LA opioid prescribing
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Tips for Managing Behavioral Issues in Elderly Patients with Dementia
Elderly patients with dementia present the practicing physician with the challenge of managing the psychiatric and behavioral spectrum of this disorder: memory problems, mood disorders, sleep disturbances, apathy, delusions, hallucinations, wandering and agitation. This session will provide assistance in the differential diagnosis and the selection of appropriate pharmacologic and non-pharmacologic treatments for behavioral problems.
Learning Objectives:
  1. Differentiate the variation in symptoms of the dementing disorders depending upon their etiology.
  2. Apply appropriate pharmacologic therapies for behavioral problems associated with dementia.
  3. Apply appropriate non-pharmacological therapies for agitation with special attention to the environment.
CLOSE  X  
Getting the Most Clinical Insights from Specific ER/LA Product Information Sources
Learning Objectives:
  1. Differentiate the prescribing information among available ER/LA opioids
  2. Identify ER/LA opioids and dosages indicated for opioid-tolerant patients only
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Medical Knowledge Brain Game: SAFE Opioid Prescribing Edition
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
 
 SAFE Opioid Prescribing | Strategies. Assessment. Fundamentals. Education.
6:30AM
 
7:00AM
 
7:30AM
 
8:00AM
 
8:30AM
 
9:00AM
 
9:30AM
 
10:00AM
 
10:30AM
 
11:00AM
 
11:30AM
 
12:00PM
 
12:30PM
 
1:00PM
 
1:30PM
 
2:00PM
 
2:30PM
 
3:00PM
 
3:30PM
 
4:00PM
 
4:30PM
 
5:00PM
 
5:30PM
 
6:30 AM-7:30 AM - Registration and Refreshments
 
 
 
7:30 AM-7:45 AM - Welcome and Opening Remarks
7:45 AM-8:45 AM
Obesity in America from the Dietary Counselor and Lifestyle Coach from "The Biggest Loser"
 
 
 
8:45 AM-9:45 AM - Networking Break and Additional Opportunities
 
 
 
9:45 AM-10:45 AM
Targeting Better Cardiac Outcomes for High-Risk Patients
9:45 AM-10:45 AM
Ultrasound in Primary Care
 
 
 
10:45 AM-11:45 AM
Understanding Dyslipidemia Testing and Screening: Importance of Lipoprotein Particle Analysis
10:45 AM-11:45 AM
Introduction to Ultrasound and Case Presentations
 
 
 
11:45 AM-1:45 PM - Networking Break and Addtional Opportunities
 
 
 
 
 
 
 
1:45 PM-2:30 PM
Evaluation is Essential for Safe and Effective Pain Management Using ER/LA Opioids
1:45 PM-2:45 PM
Engaging e-Patients: How e-Messaging, Personal Health Records, and Patient Activation Can Transform Your Practice
1:45 PM-6:00 PM
Ultrasound Workshops | Hands-on workshops developed with the University of South Carolina Ultrasound Institute offered at an additional cost
 
 
2:30 PM-3:00 PM
Best Practices for How to Start Therapy with ER/LA Opioids, How to Stop, and What to Do in Between
2:45 PM-3:45 PM
Test Your Skills in Difficult Cases: Atrial Fibrillation
3:00 PM-3:45 PM
Evidence-Based Tools for Screening for Patients at Risk and Monitoring for Adherence to Prescribed ER/LA Opioids
 
 
3:45 PM-4:00 PM - Networking Break
4:00 PM-4:30 PM
Talk to Me: Proven Methods to Counsel Your Patients on ER/LA Opioids and Achieve Positive Outcomes
4:00 PM-5:00 PM
An Algorithmic Approach to Diabetes Management: Insulin-Based Therapy
 
4:30 PM-5:00 PM
Everything You Always Wanted to Know About ER/LA-Opioids as a Drug Class
 
5:00 PM-5:30 PM
Getting the Most Clinical Insights from Specific ER/LA Product Information Sources
5:00 PM-6:00 PM
Tips for Managing Behavioral Issues in Elderly Patients with Dementia
 
5:30 PM-6:00 PM
Medical Knowledge Brain Game: SAFE Opioid Prescribing Edition
 
CLOSE  X  
Registration and Refreshments
CLOSE  X  
Welcome and Opening Remarks
CLOSE  X  
Session Information to Come
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Obstructive Sleep Apnea: Interventions That Will Help Your Patients Sleep Better
This session will provide guidance on whom to screen for obstructive sleep apnea in your primary care practice, how to screen, interventions and the differences you will encounter between male and female patients with this condition.
Learning Objectives:
  1. Implement practice-based procedures to screen and manage patients at risk for or with evidence of obstructive sleep apnea.
  2. Co-manage patients with OSA and encourage continued monitoring and compliance with CPAP therapy.
CLOSE  X  
Improve Patient Outcomes with Effective Diagnosis and Treatment of Underlying Psychiatric Disorders
Improve your recognition of the signs and symptoms of major depressive disorder with differentiation from bipolar disorder. Improve your knowledge in the best practice selection of pharmacologic treatments for patients with uncomplicated depression and somatization.
Learning Objectives:
  1. Recognize the signs and symptoms of major depressive disorder (MDD) and initiate therapy with close monitoring.
  2. Differentiate bipolar disease from symptoms of depression in order to determine appropriate treatment.
  3. Consider actions and side effects of drugs and drug classes when deciding on which treatment to select for patients with psychiatric disorders.
CLOSE  X  
Fighting a Growing Epidemic: A Viral Hepatitis Update
This session will provide up-to-date guidelines for screening and evaluating patients with HCV virus infection in the primary care setting. Current best evidence will be presented to guide initiation of antiviral therapy and treatment monitoring for HCV and HBV.
Learning Objectives:
  1. Assess updated guidelines for screening and evaluating patients for HCV in the primary care setting.
  2. Direct antiviral therapy for HCV and HBV using best available evidence.
  3. Monitor patients for antiviral treatment response and toxicities.
CLOSE  X  
VTE Prevention: Avoiding the Avoidable in Medical and High-Risk Patients
Venous thromboembolism (VTE) is a disease that includes both deep vein thrombosis and pulmonary embolism. This session will assist you in identifying high risk medical and hospitalized patients in whom thromboprophylaxis should be initiated and appropriate oral regimens for extended thromboprophylaxis after hospital discharge.
Learning Objectives:
  1. Identify high risk medical and hospitalized patients for whom thromboprophylaxis should be initiated.
  2. Determine appropriate oral regimens for extended thromboprophylaxis after hospital discharge.
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Live Demonstration Orthopedic Exam: See It, Do it
Learn orthopedic maneuvers to assess common office-based musculoskeletal complaints.
Learning Objectives:
  1. Through live demonstration of orthopedic maneuvers, you will improve your ability to diagnose common musculoskeletal complaints of the upper body, low back, hip, and knee.
CLOSE  X  
Infectious Diseases Update in Primary Care
This infectious disease update session provides guidance on applying current clinical guidelines to the diagnosis and treatment of acute bacterial sinusitis, differential diagnosis and management of latent tuberculosis infection, and evidence-based management of genital herpes.
Learning Objectives:
  1. Apply current clinical guidelines to the diagnosis and treatment of acute bacterial sinusitis.
  2. Differentiate the diagnosis of latent tuberculosis infection from that of active tuberculosis.
  3. Apply current evidence and guidelines to the clinical management of genital herpes.
CLOSE  X  
Finding Clinical Value in EHR Meaningful Use
Many physicians are wary of the time and resource commitment to implementing an EHR in their practice. This session will provide tangible examples of the value of EHRs and meaningful use in your practice, with suggestions for next steps in their use. *This activity meets the criteria of the Massachusetts Board of Medicine in Medicine for 1 credit of Electronic Health Records. Please check your individual state licensing board requirements before claiming EHR credit.
Learning Objectives:
  1. Understand the rationale for and intentions of Meaningful Use.
  2. Identify examples creating value from EHRs and Meaningful Use.
CLOSE  X  
Networking Break
CLOSE  X  
Lipid Management: A Primary Care Perspective
Be up to date on current studies evaluating the benefits of raising HDL in reducing CV risk and how intense treatment should be to reduce residual risk for CHD.
Learning Objectives:
  1. Utilize evidence-based lipoprotein management strategies for non-LDL-C lipid targets.
  2. Describe the risk factors, disease spectrum, and appropriate management of familial hypercholesterolemia.
CLOSE  X  
The Problem Pests: Ticks, Mites, Bedbugs, and Lice
This session will provide you with actionable information regarding insect pest borne infectious diseases, including the topic of the manifestations of Lyme disease and test interpretation to manage these patients and identifying body lice infestation with patient education regarding treatment and prevention.
Learning Objectives:
  1. Differentially diagnose common tick-borne diseases using symptomology, epidemiologic evidence, and lab tests, and prescribe antibiotic therapy as indicated.
  2. Diagnose and manage clinical manifestations of common pest infestations, including lice, mites, and bed bugs.
CLOSE  X  
New Insights into Reducing CV Risk in Patients with Type 2 Diabetes
This session will provide actionable information for implementing current evidence-based guidelines to reduce CVD risk in type 2 diabetes patients and will utilize a case-based approach that addresses CV risk factors such a dyslipidemia and hypertension in these patients.
Learning Objectives:
  1. Identify key factors associated with increased cardiovascular outcomes in patients with type 2 diabetes
  2. Implement current evidence-based guidelines to reduce the risk of CV disease in patients with type 2 diabetes mellitus
CLOSE  X  
Critical Caveats for Common Medications
Case-based review of side effects and drug interactions encountered with commonly used medications, including proton pump inhibitors, triptans, antibiotics, anticoagulants, NSAIDs and antidepressants.
Learning Objectives:
  1. Effectively manage patients who are on statin therapy with respect to potential drug interactions and muscle-related symptoms.
  2. Consider potential adverse effects of proton pump inhibitors, such as impaired absorption of certain nutrients, when prescribing as long-term therapy.
6:30AM
 
7:00AM
 
7:30AM
 
8:00AM
 
8:30AM
 
9:00AM
 
9:30AM
 
10:00AM
 
10:30AM
 
11:00AM
 
11:30AM
 
12:00PM
 
12:30PM
 
1:00PM
 
1:30PM
 
2:00PM
 
2:30PM
 
3:00PM
 
3:30PM
 
4:00PM
 
4:30PM
 
5:00PM
 
5:30PM
 
6:30 AM-7:30 AM - Registration and Refreshments
 
 
 
7:30 AM-7:45 AM - Welcome and Opening Remarks
7:45 AM-8:45 AM
Session Information to Come
 
 
 
8:45 AM-9:45 AM - Networking Break and Additional Opportunities
 
 
 
9:45 AM-10:45 AM
Obstructive Sleep Apnea: Interventions That Will Help Your Patients Sleep Better
9:45 AM-10:45 AM
Improve Patient Outcomes with Effective Diagnosis and Treatment of Underlying Psychiatric Disorders
 
 
 
10:45 AM-11:45 AM
VTE Prevention: Avoiding the Avoidable in Medical and High-Risk Patients
10:45 AM-11:45 AM
Fighting a Growing Epidemic: A Viral Hepatitis Update
 
 
 
11:45 AM-1:45 PM - Networking Break and Additional Opportunities
 
 
 
 
 
 
 
1:45 PM-3:45 PM
Live Demonstration Orthopedic Exam: See It, Do it
1:45 PM-2:45 PM
Infectious Diseases Update in Primary Care
 
 
 
2:45 PM-3:45 PM
Finding Clinical Value in EHR Meaningful Use
 
 
 
3:45 PM-4:00 PM - Networking Break
4:00 PM-5:00 PM
Lipid Management: A Primary Care Perspective
4:00 PM-5:00 PM
The Problem Pests: Ticks, Mites, Bedbugs, and Lice
 
 
 
5:00 PM-6:00 PM
New Insights into Reducing CV Risk in Patients with Type 2 Diabetes
5:00 PM-6:00 PM
Critical Caveats for Common Medications
 
 
 
CLOSE  X  
Registration and Refreshments
CLOSE  X  
Welcome and Opening Remarks
CLOSE  X  
Session Information to Come
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Women’s Health Update: Clinical Pearls for Primary Care
A review of the spectrum of common health concerns in postmenopausal women and their prevention and management.
Learning Objectives:
  1. Weigh the evidence for benefits versus harms when considering hormone replacement therapy for women with menopausal symptoms.
  2. Proactively screen and treat elderly women to prevent falls and fractures.
CLOSE  X  
Management of the Long-Term Effects of Cancer and Cancer Therapy in Primary Care
Cardiovascular health is increasingly becoming an issue in long-term cancer survivors, requiring closer attention to its management. Learn how to assess and address cardiovascular risk in cancer survivors.
Learning Objectives:
  1. Explore the evidence regarding cardiovascular disease in survivors of certain types of cancer.
  2. Encourage cancer survivor patients to adopt healthy lifestyles to reduce CV and cancer risk.
  3. Implement screening guidelines for cancer survivors to reduce future cancer risk.
CLOSE  X  
Lung Sounds: A Primer on Pulmonary Auscultation
This primer on pulmonary auscultation will permit you to identify various breath sounds and adventitious lung sounds, including those findings which have been described only recently, and link them to the scientific and literature validation that supports their clinical relevancy.
Learning Objectives:
  1. Recognize and identify various breath sounds and adventitious lung sounds, including those findings which have been described only recently.
  2. Link literature validation and scientific basis to those sounds and extra-sounds which are clinically relevant.
  3. Establish a clinico-pathologic correlation for sounds and extra-sounds and murmurs.
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
In Search of Joy in Practice
CLOSE  X  
Session Information to Come
 
 
6:30AM
 
7:00AM
 
7:30AM
 
8:00AM
 
8:30AM
 
9:00AM
 
9:30AM
 
10:00AM
 
10:30AM
 
11:00AM
 
11:30AM
 
12:00PM
 
12:30PM
 
1:00PM
 
1:30PM
 
2:00PM
 
2:30PM
 
3:00PM
 
3:30PM
 
6:30 AM-7:30 AM - Registration and Refreshments
 
 
 
7:30 AM-7:45 AM - Welcome and Opening Remarks
7:45 AM-8:45 AM
Session Information to Come
 
 
 
8:45 AM-9:45 AM - Networking Break and Additional Opportunities
 
 
 
9:45 AM-10:45 AM
Women’s Health Update: Clinical Pearls for Primary Care
9:45 AM-11:45 AM
Management of the Long-Term Effects of Cancer and Cancer Therapy in Primary Care
 
 
 
10:45 AM-11:45 AM
Lung Sounds: A Primer on Pulmonary Auscultation
 
 
 
11:45 AM-1:45 PM - Networking Break and Additional Opportunities
 
 
 
 
 
 
 
1:45 PM-2:45 PM
In Search of Joy in Practice
 
 
 
2:45 PM-3:45 PM
Session Information to Come
 
 
 

Ticketed Events

For 2014, Pri-Med is implementing a new ticketing policy to give all attendees equal opportunity to attend the additional events within the conference. Distribution of all additional opportunity tickets will happen on-site on a first-come, first-served basis at the Ticket Booth. Please check-in early to ensure tickets are available for the additional opportunities you want to participate in. Limit 4 tickets per person.

A schedule of ticketed events coming soon.

Accreditation

Earn up to 26 AMA PRA Category 1 Credits™ or 26 AANP contact hours of continuing education.

Final session schedule is pending. Credits estimated based on current schedule.

Primary Care Updates
September 11, 2014
Credits Type Accreditation Statement Designation Statement
7 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live educational activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pending AAFP Application for CME credit has been filed with American Academy of Family Physicians. Determination of credit is pending.
7 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 7 contact hours of continuing education (which includes 3.500 hours of pharmacology).
Annual Conference
September 12—14, 2014
Credits Type Accreditation Statement Designation Statement
19 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live educational activity for a maximum of 19 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pending AAFP Application for CME credit has been filed with American Academy of Family Physicians. Determination of credit is pending.
19 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 19 contact hours of continuing education (which includes 9.500 hours of pharmacology).

Keynote Speakers

Michael Dansinger, MD (Read Bio)

Presenting on:

Exhibit Hall

Pri-Med Exhibit Hall

Hours
Friday, September 12 8:30am–2:30pm
Saturday, September 13 8:30am–2:30pm
Sunday, September 14 8:30am–2pm

The Pri-Med Exhibit Hall is your chance to learn about and compare hundreds of the health care industry’s latest products, treatments, and technologies in one place.


Spend your time in the Exhibit Hall talking to company representatives, evaluating new options, and making purchasing decisions for your practice—all things you do not have time for in your daily schedule. 

Attendee Badge Information

Please Note: As a Pri-Med registrant, you will receive a badge and an Attendance Scan Card, which will have bar codes programmed with your name, address, and professional discipline. You will scan your bar code at the appropriate stations to obtain CME credit or nursing contact hours.

Scanning your card at an exhibit booth or non-CME activity gives the sponsor permission to use your contact information for future correspondence.

 

Pri-Med Mobile App Coming Soon

Exhibit Floor Highlights

Presentation Theaters
Join us for an informative snack break, lunch, or dinner discussion about the latest clinical information as it relates to a specific disease state.

Pri-Med Recharge Lounge
Relax. Recharge. Refuel. Visit this booth for complimentary coffee and small snacks during some of the break times.

Pri-Med Solutions Center
Stop by the Solutions Center to have any questions answered, update your contact information, find out about online resources and tools, and register for Pri-Med East 2015.

Amazing Charts
Visit the #1-rated EHR, Amazing Charts to start a FREE trial and get FREE Pri‑Med 2015 registration.

While you’re in session, we’ll get you started with a trial of Amazing Charts on your laptop** and give you a 1-on-1 demo when you return to pick it up.

**See minimum system specifications at amazingcharts.com/specs.

Exhibitor List

Company Name Booth Number
AbbVie 1925
Akrimax Pharmaceuticals LLC 1027
Amazing Charts 1329
American Express Open 1809
AndaMEDS 1223
Astellas Pharma U.S., Inc. 2124
Auxilium Pharmaceuticals, Inc. 1713
Bankers Healthcare Group, Inc. 1222
Bionix Medical Technologies 2127
Calmoseptine 1731
Cell Science Systems/ ALCAT 2008
CryoProbe 1010
Diva International Inc. 1715
Edge Systems Corporation 1008
Elsevier Medical Books 1019
Gensco Laboratories 1028
Grifols USA, Inc. 1322
Hemosure Inc. 1323
International Tree Nut Council Nutrition Research & Education Foundation 2108
Janssen Pharmaceuticals, Inc. 1108
Kareo 2131
Laclede Inc 1513
LocumTenens.com 1716
Magine Events 1032
Merck 1618
Minute Clinic 1831
Monthly Prescribing Reference 1022
Neilmed Pharmaceuticals, Inc. 1515
New York Times 1812
Nutramax Laboratories, Inc. 1012
Omron Healthcare 1016
PA Beef Council 2112
Renua Medical 1132
Salix Pharmaceuticals, Inc. 1422
Sanofi Pasteur Inc. 1915
Shire 1532
Southcoast Hospitals Group 2119
Take Shape for Life 1518
Tec Laboratories, Inc. 1519
The Gideons International 1610
Upsher-Smith Laboratories, Inc. 1014
Vital Nutrients 2130
Company Name Booth Number
Aegis Sciences Corporation 1612
Amarin Pharma, Inc. 1315
American College of Physicians 1412
American Latex Allergy Association (ALAA) 1015
Aspirin Works By Corgenix 1021
AstraZeneca 1218
Auxilium Pharmaceuticals, Inc. 1815
Bassett Healthcare 1023
Boehringer Ingelheim Pharmaceuticals, Inc. 1129
Cegedim 1024
Crown Healthcare Apparel Service 1934
CryoSurgery, Inc 1030
Doximity 1418
Eisai, Inc. 1425
Forest Pharmaceuticals, Inc. 1125
Gilead Sciences 1115
Health Diagnostic Laboratory 1312
I.C. E., Inc. 1509
IPC The Hospitalist Company 1813
Journal Watch 1420
Kowa Pharmaceuticals 1820
Lippincott Williams & Wilkins 1025
Magic Massage Therapy 1708
Maico Diagnostics 1031
Micro Direct, Inc. 2116
Mission Pharmacal Co 1122
Mylan Specialty 1729
New England Journal of Medicine 1419
Novo Nordisk Inc. 1822
OAPI- Medical Device Division 1615
Otto Trading, Inc. 1910
Pfizer Inc. 1929
Rome Foundation 1613
Sanofi 2118
Scarf King 1608
Singulex Inc. 1712
Summit Doppler Systems 1512
Takeda Pharmaceuticals U.S.A., Inc. 1625
Televox Software, Inc. 1520
Ultimate Creations 1709
Vita Mix Corp 1808
WynnPharm Inc. 1018
Start:  End: 
Expand Expand Instructions Print PrintMap

Travel Arrangements

Meeting Location

Boston Convention & Exhibition Center
415 Summer St
Boston, MA 02210-1709
(617) 954-2000

Hotel Accommodations